NEW YORK, Sept. 16, 2025 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced a comprehensive shareholder update, underscoring momentum across its lead clinical programs and corporate strategy. With HT-001 advancing globally, HT-KIT […]
Resilience
Karmanos Cancer Institute's BMT, Hematology and Multiple Myeloma Teams Welcome New Physician
Physician specializes in stem cell transplantation for blood cancers DETROIT, Sept. 16, 2025 /PRNewswire/ — The Barbara Ann Karmanos Cancer Institute welcomes Bradley Rockwell, M.D., transplant hematologist. Dr. Rockwell is a member of the Bone Marrow […]
HIGH Q TECHNOLOGIES INTRODUCES EPR SAMPLE MEASUREMENT SERVICE TO ADVANCE PROTEIN STRUCTURE RESEARCH
WATERLOO, ON, Sept. 16, 2025 /PRNewswire/ – High Q Technologies, an innovative manufacturer of quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers, announced the launch of the High Q Sample Measurement Service today. Aimed at the structural […]
Akeso's Ligufalimab (CD47 mAb) Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia (AML)
HONG KONG, Sept. 15, 2025 /PRNewswire/ — Akeso Inc. (9926.HK) today announced that its proprietary next-generation humanized IgG4 monoclonal antibody targeting CD47, ligufalimab (AK117), has been granted Orphan Drug Designation (ODD) by the U.S. FDA […]
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
SAN FRANCISCO and SUZHOU, China, Sept. 15, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology […]